AstraZeneca's suspension of global trials of its experimental coronavirus vaccine after an unexplained illness in a study subject in Britain has cast doubt on prospects for an early rollout.
FILE PHOTO: The company logo for pharmaceutical company AstraZeneca is displayed on a screen on the floor at the New York Stock Exchange in New York, U.S., April 8, 2019. REUTERS/Brendan McDermid/File Photo
The vaccine, which Britain’s AstraZeneca is developing with the University of Oxford, has been described by the World Health Organization as probably the world’s leading candidate and the furthest developed. “It is obviously a challenge to this particular vaccine trial,” Britain’s Health Secretary Matt Hancock told Sky News.The patient was suffering from neurological symptoms associated with a rare spinal inflammatory disorder called transverse myelitis, said Chief Executive Pascal Soriot, according to Stat News, citing investors who had listened to a call it said was organised by J.P. Morgan.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Pause in AstraZeneca vaccine trial not necessarily a setback, says UK health ministerBritain's Health Secretary Matt Hancock said on Wednesday that AstraZeneca's decision to pause its coronavirus vaccine trials was a challenge but would not necessarily set back efforts to develop a vaccine.
Read more »
AstraZeneca suspends leading COVID-19 vaccine trials after a participant's illnessAstraZeneca Plc said it has paused global trials, including large late-stage trials, of its experimental coronavirus vaccine due to an unexplained illness in a study participant.
Read more »
AstraZeneca puts leading COVID-19 vaccine trial on hold over safety concernAstraZeneca Plc on Tuesday said it has paused global trials, including large late-stage trials, of its experimental coronavirus vaccine because of an unexplained illness in a study participant.
Read more »
AstraZeneca trial pause is ‘not necessarily’ a setback, British health minister saysThe U.K.'s health minister on Wednesday rushed to defend AstraZeneca's decision to pause a closely-watched coronavirus vaccine trial due to safety concerns.
Read more »
Collins and Adams face Senate health panelTwo top health officials are testifying this morning on vaccine progress in front of the Senate's health committee
Read more »
AstraZeneca Pauses COVID-19 Vaccine Trial Due To Volunteer's IllnessNPR's Noel King talks to Paul Offit of the Vaccine Education Center at Children's Hospital of Philadelphia, about the coronavirus vaccine trial developed by AstraZeneca and the University of Oxford.
Read more »